How many insider trades does FilingIQ track for NVNO?

FilingIQ tracks 28 Form 4 insider transactions for NVNO (enVVeno Medical Corp), covering filings from Nov 16, 2021 onwards. 1 of those were filed in the last 90 days.

Are NVNO insiders net buyers or net sellers?

Across the full Form 4 history for NVNO, 10 transactions (36%) were open-market purchases and 4 (14%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.

Where does NVNO insider data come from?

Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ parses the raw XML, normalises insider identity across reporting variations, and scores each trade on its multi-factor composite model.

What sector is NVNO in?

enVVeno Medical Corp (NVNO) is classified in the Healthcare sector, specifically Medical Devices, with a current market capitalisation of $7.21M.

NVNO insider trading

NasdaqCM Healthcare

enVVeno Medical Corp — scored insider trade history from SEC Form 4 filings, parsed and contextualised by FilingIQ.

Total Form 4 trades

Last 90 days

Buys / sells

36% / 14%

Market cap

$7.21M

About enVVeno Medical Corp

enVVeno Medical Corporation, a clinical-stage medical device company, focuses on the development of bioprosthetic tissue-based solutions to enhance the standard of care in the treatment of venous disease. The company's lead product is the VenoValve, a replacement venous valve for the treatment of venous chronic venous insufficiency. Its VenoValve implanted into the femoral vein of the patient in an open surgical procedure via a 5-to-6-inch incision in the upper thigh. The company also develops enVVe, a non-surgical and transcatheter-based replacement venous valve system consisting of the enVVe valve, enVVe delivery system, and delivery system accessories. The company was formerly known as Hancock Jaffe Laboratories, Inc. and changed its name to enVVeno Medical Corporation in October 2021. enVVeno Medical Corporation was incorporated in 1999 and is based in Irvine, California.

Company website: www.envveno.com

NVNO insider activity at a glance

FilingIQ has scored 28 insider transactions for NVNO since Nov 16, 2021. The most recent filing in our index is dated Mar 12, 2026.

Across the full history, 10 open-market purchases and 4 open-market sales were filed under transaction codes P and S respectively. Compensatory share awards (code A) and option exercises (code M) are tracked separately and not counted here.

The average FilingIQ composite score on NVNO insider trades is 65.4/100, produced by FilingIQ's multi-factor Form 4 model. Model framework documented at methodology.

View live NVNO trades on FilingIQ Raw filings on SEC EDGAR

Latest NVNO Form 4 filings

BERMAN ROBERT ANDREW Chief Executive Officer

P Dec 19, 2024

Alavi Hamed Chief Technology Officer

S Mar 13, 2024

Most recent disclosures. Sign up to filter by score, transaction code, or insider role.

Other Healthcare tickers with recent insider activity

UTHR 1,098

UNITED THERAPEUTICS Corp

APLS 279

Apellis Pharmaceuticals, Inc.

KMDA 218

KAMADA LTD

BMY 185

BRISTOL MYERS SQUIBB CO

ADPT 184

Adaptive Biotechnologies Corp

GH 169

Guardant Health, Inc.

ISRG 166

INTUITIVE SURGICAL INC

VTRS 165

Viatris Inc

Frequently asked

How many insider trades does FilingIQ track for NVNO?: FilingIQ tracks 28 Form 4 insider transactions for NVNO (enVVeno Medical Corp), covering filings from Nov 16, 2021 onwards. 1 of those were filed in the last 90 days.
Are NVNO insiders net buyers or net sellers?: Across the full Form 4 history for NVNO, 10 transactions (36%) were open-market purchases and 4 (14%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.
Where does NVNO insider data come from?: Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ parses the raw XML, normalises insider identity across reporting variations, and scores each trade on its multi-factor composite model.
What sector is NVNO in?: enVVeno Medical Corp (NVNO) is classified in the Healthcare sector, specifically Medical Devices, with a current market capitalisation of $7.21M.

Methodology & sources

Every NVNO insider transaction shown on FilingIQ is parsed directly from a public SEC Form 4 XML filing. Insider identity is normalised across reporting variants (CIK changes, name spellings, related-party indirect holdings). The FilingIQ composite score is documented in full on the team page and algo disclosure. Not investment advice; see disclaimer.